US FDA Commissioner Admonishes Health Care Stakeholders To Know Agency Better, Help More
Executive Summary
Califf was candid during an FDA Science Board meeting about the agency’s limits, such as disseminating accurate information in response to rampant misinformation during COVID-19 pandemic. “We need to call out people who are outside the FDA … because this vast universe of information out there is way bigger than we can handle on our own,” he said.
You may also be interested in...
Democrat, Republican Pioneer Women In US House Won’t Return After 2024 Elections
Granger’s exit means House Appropriations will have different chair no matter which party wins majority 2024 elections; Democrats will lose senior House Energy and Commerce Health Subcommittee member with Eshoo’s retirement.
After At-Home Diagnostics Got Boost From COVID, FTC Shows False Claims Didn’t End With Pandemic
FTC and California Attorney General offer CRI Genetics LLC as exhibit A for making good on promised deliverables for DNA-based ancestry and information reports.
Tianeptine Rings Latest Unapproved Drug Alarm, Followed By Echo About Lack Of FDA Regulation
Tianeptine isn’t approved as drug in US nor allowed for use as dietary ingredient or food additive. FDA has warned multiple firms selling tianeptine-containing products and federal prosecutors recently announced guilty plea from man who sold the drug to consumers.